YDES Kronos AI forecast
A 30-trading-day price forecast for YD Bio Limited (YDES) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts YD Bio Limited at $3.82 on 2026-12-08, −36.8% from the last close of $6.04 on 2026-10-27. Eight out of ten sampled paths end between $2.54 and $4.72, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of YDES
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $5.61 | $4.89 | $5.94 |
| 2026-11-10 | $5.30 | $4.18 | $6.16 |
| 2026-11-17 | $4.64 | $4.10 | $5.95 |
| 2026-11-24 | $4.36 | $2.76 | $4.94 |
| 2026-12-01 | $4.32 | $3.14 | $4.54 |
| 2026-12-08 | $3.82 | $2.54 | $4.72 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for YDES?
- Kronos AI's median forecast for YDES is $3.82 in 30 trading days, −36.8% from the last close, with a 10–90% range of $2.54 to $4.72.
- Is the YDES Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- UNH — UnitedHealth Group Incorporated
- ELV — Elevance Health Inc.
- CI — The Cigna Group
- NTRA — Natera Inc.
- HUM — Humana Inc.
- ILMN — Illumina Inc.